|
Hyaluronan assessment in tumor microenvironment using new affinity histochemistry assay and scoring method. |
|
|
Employment - Ventana Medical Systems |
Patents, Royalties, Other Intellectual Property - Ventana Medical Systems (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - Ventana Medical Systems |
Stock and Other Ownership Interests - Roche |
|
Travel, Accommodations, Expenses - Roche |
|
|
|
Stock and Other Ownership Interests - Halozyme |
Patents, Royalties, Other Intellectual Property - Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof: Sep.30, 2014 (Inst) |
|
|
|
Stock and Other Ownership Interests - Halozyme |
|
|
|
Stock and Other Ownership Interests - Exelixis; Halozyme |
Consulting or Advisory Role - Anacor; Bayer; Mitomics; Zenith Epigenetics |
|
|
Employment - Ventana Medical Systems |
Stock and Other Ownership Interests - Ventana Medical Systems |
Travel, Accommodations, Expenses - Ventana Medical Systems |
|
|
No Relationships to Disclose |
|
|
Employment - Ventana Medical Systems |
Stock and Other Ownership Interests - Ventana Medical Systems |
Patents, Royalties, Other Intellectual Property - Pending Patent (Inst) |